Lysine

Quick links to important sections

Lysine

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lysine

Property Description
Active ingredient L-Lysine Monohydrochloride
Common Forms Oral tablets, capsules, liquid solutions
Pharmacological Class Amino Acid / Nutritional Agent
Origin Natural (Essential Amino Acid)
General Purpose Supports growth, tissue repair, and structural health

L-Lysine is an essential amino acid classified as a nutritional agent used to support various physiological functions; it is a fundamental protein building block that the human body requires but cannot manufacture itself. Because it is essential, L-Lysine must be consistently acquired through diet or, in pharmaceutical contexts, through supplementation. The designation of Lysine as an essential nutrient is widely clinically recognized, underscoring its foundational role in human health.


What Type of Substance is L-Lysine?

Lysine is a natural substance, chemically identified as alpha,varepsilon-diaminocaproic acid (C6H14N2O2), which places it within the larger pharmacological class of amino acids. As an essential nutrient, its primary therapeutic role is to ensure the body's baseline requirements are met for synthesizing the thousands of structural and functional proteins necessary for life. L-Lysine is typically prepared and delivered as L-Lysine Monohydrochloride, a stabilized salt form that optimizes its solubility and absorption in the body, making it a reliable source for oral or parenteral (injectable) route of administration. The established status of Lysine highlights its critical involvement in human metabolism.


What is the General Purpose of Lysine Therapy?

The general purpose of Lysine therapy is to support growth and tissue repair by providing the necessary foundational element for collagen and other essential molecules. L-Lysine plays a critical part in the formation of collagen, the primary protein that lends structure and strength to skin, bones, and connective tissues. Furthermore, it actively promotes the necessary absorption of calcium in the gut and supports the synthesis of carnitine, which aids in energy production. Lysine maintains a dual role in both protein synthesis and calcium homeostasis.

Regulatory References

  1. Lysine role in collagen Cleveland Clinic
  2. Lysine absorption of calcium WebMD

What side effects are possible with Lysine?

Possible Side Effects and Safety Information

The following safety information is derived from authoritative government regulatory documents and health publications, focusing on officially documented adverse reactions and restrictions.

Adverse Reactions

The most frequently reported adverse effects associated with oral intake involve the Gastrointestinal System and are classified as Common. These typically include:

  • Stomach pain
  • Diarrhea

Serious Adverse Reactions

While considered rare, the possibility of a serious systemic allergic reaction (hypersensitivity) has been documented. Signs such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat are considered emergency medical situations.

Adverse Reaction Category Primary Body System Frequency Class
Gastrointestinal Symptoms Gastrointestinal Common
Allergic Reaction Immune System Not Known (Serious)

Population-Specific Safety Considerations and Restrictions

Official documents indicate that caution or restricted use is necessary for specific patient populations. These include:

  • Lysinuric Protein Intolerance: Use is cautioned in children with this rare genetic disorder due to potential adverse effects.
  • Kidney Disease: Individuals with existing kidney impairment should use L-lysine with caution, as some regulatory reports note an association with chronic kidney failure and interstitial nephritis.
  • Pregnancy and Breast-feeding: Safety is not reliably established; therefore, use is cautioned or advised against during these periods.

Safety-Related Interactions

Regulatory information documents potential interactions with other substances:

  • Calcium Supplements: L-lysine can increase the absorption of calcium, which may lead to excessive calcium levels in the body.
  • Gastrointestinal Medicines: The use of L-lysine may reduce the effectiveness of certain gastrointestinal drugs, specifically 5-HT4 agonists (e.g., prucalopride, tegaserod).
  • Aminoglycoside Antibiotics: Concomitant use with drugs such as gentamicin may increase the potential for kidney toxicity.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for L-Lysine overdose, reflecting its status as an essential amino acid, focuses primarily on managing gastrointestinal manifestations and mandating immediate emergency contact.

Documented Overdose Presentations

Excessive oral ingestion or overdose has been formally documented to present with signs of gastrointestinal distress. These documented manifestations include common transient symptoms such as diarrhea and stomach pain (abdominal pain). The information emphasizes that while these effects are typically transient, they define the known symptomatic presentation of overdose.

Required Emergency Action

In the event of suspected overdose, regulatory guidance mandates immediate professional assistance. The specific actions required are to seek emergency medical attention or to contact a Poison Control Center right away. These actions must be taken promptly, regardless of the initial symptoms observed.

Population-Specific Considerations

A specific risk is noted in official documents for individuals diagnosed with lysinuric protein intolerance, a metabolic disorder that can be exacerbated by excessive amino acid intake, particularly in children. For overdose of concentrated intravenous solutions, clinical guidance dictates procedural steps like temporary infusion interruption, close monitoring for hyperkalaemia, and measures to promote elimination, such as forced diuresis, to manage potential solute overload risks.

Therapeutic Uses of Lysine

Quick Facts

  • May help: Prevent outbreaks and reduce the severity of cold sores (herpes simplex labialis).
  • Supports: Normal growth, the production of carnitine, and calcium absorption.
  • May assist: In maintaining healthy tissue and collagen formation.

What Lysine treats: main uses and benefits

Lysine is an essential amino acid that the body needs for a variety of critical functions, including protein synthesis and tissue maintenance. Because the body cannot produce this nutrient, it must be obtained through dietary intake or supplementation. Lysine is a necessary component for normal growth and development.

In a therapeutic context, Lysine may help in the management of cold sores (herpes simplex virus infection). Lysine supplementation may reduce the frequency of outbreaks and may contribute to the healing of these lesions. This potential effect is attributed to its relationship with another amino acid, arginine, which the virus requires for replication.

Lysine supports the body's absorption and retention of calcium, a process that is vital for bone health. It also plays a role in the production of carnitine, a molecule involved in converting fatty acids into energy, and is crucial for collagen formation, which provides structure to skin and connective tissues.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Lysine — Official Regulatory Information

The following information is based on official labeling for Lysine when used as part of LysaKare (a combination with L-arginine) to protect the kidneys during specific radionuclide therapy (PRRT).


Eligibility Scope

Classification Population/Condition
Populations for Whom Use is Allowed Adults undergoing peptide-receptor radionuclide therapy (PRRT) with lutetium (^177mathrmLu) oxodotreotide.
Contraindicated Patients with severe renal impairment (creatinine clearance <30mathrm~mL/min).
Contraindicated Patients with pre-existing, clinically significant, and uncorrected hyperkalaemia.
Use Not Established Pediatric patients (below 18 years), as safety and efficacy have not been established.
Use with Caution Patients with moderate renal impairment (creatinine clearance 30 to 50mathrm~mL/min).
Use with Caution Patients with severe heart failure (NYHA class III or IV) due to volume overload risk.

Connection to the Overall Eligibility Profile

The official eligibility profile for this Lysine-containing medicine is strictly defined by the need to prevent kidney damage during a specialized cancer treatment. Use is contraindicated in patients with severely reduced kidney function or high blood potassium levels. Furthermore, special caution and benefit-risk assessment are required for individuals with moderate kidney impairment or severe heart failure due to potential clinical complications, and its use is not established for anyone under 18 years of age.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for L-lysine, an essential amino acid, is limited in scope compared to conventional pharmaceuticals, focusing primarily on its interaction with other nutrients and supplements as documented in authoritative regulatory sources.

Documented Interaction Categories

Interacting Product Category Interaction Statement (Based on Regulatory Labeling)
Mineral Supplements L-lysine may increase the absorption and retention of Calcium. Large amounts of L-lysine should be avoided with large amounts of Calcium supplements.
Amino Acid Supplements L-lysine may compete with L-arginine for absorption and transport, potentially affecting the action or metabolism of L-arginine.

Regulatory Summary

Regulatory documents emphasize that the most significant documented interaction involves Mineral Homeostasis Modification, specifically with calcium. This interaction may result in an additive effect, where L-lysine enhances the body’s uptake of calcium. Therefore, caution is warranted regarding high-dose co-administration with Calcium supplements. The competitive interaction with L-arginine is also noted in official sources, reflecting the amino acid's transport mechanisms. No specific interactions mediated by cytochrome P450 (CYP) enzymes or common drug transporters (P-gp, OATP) are typically documented for L-lysine.

Mechanism of Action

How Lysine Works: Mechanism of Action

Lysine exerts its mechanistic influence across three primary domains: competitive inhibition, substrate provision, and transport modulation.

Modulating Cellular Amino Acid Balance

Lysine acts as a competitive inhibitor of the amino acid Arginine at shared cationic amino acid transporters on the cell surface. This molecular competition reduces the cellular availability of Arginine, which is essential for certain biological processes. The resulting reduction in Arginine availability influences subsequent cellular processes that depend on this amino acid for protein synthesis and structure.

Structural Integrity and Tissue Stabilization

Lysine is a vital substrate required for the synthesis of the structural protein collagen. It is chemically modified to hydroxylysine by the enzyme lysyl hydroxylase, forming the strong cross-links that lend tensile strength and rigidity to tissues. The resulting cross-links contribute to the structural integrity of the extracellular matrix.

Metabolic Precursor and Mineral Regulation

Lysine functions as a precursor in the pathway for synthesizing L-Carnitine, a molecule necessary for the transport of fatty acids into mitochondria for energy production. Furthermore, Lysine is mechanistically linked to promoting the intestinal absorption and subsequent renal retention of calcium ( Ca^2+). This action modulates the transport of long-chain fatty acids into the mitochondria and influences the systemic balance of calcium.

Dosage and Administration Information

How to Use L-Lysine: Administration Guidelines

The following instructions summarize the administration and dosing parameters for L-Lysine (typically as L-Lysine Monohydrochloride).


Administration Scope

Parameter Instruction
Route of Administration Primarily Oral (capsules, tablets, powder, liquid). Also used Intravenously (IV) as an amino acid component in Total Parenteral Nutrition (TPN) solutions. Topical preparations (creams) are available for external use.
Standard Oral Dosing Common adult daily dosages are within the range of 1,000 mg to 3,000 mg (1 g to 3 g) daily. The specific dose should follow the product label.
Frequency and Timing Oral forms are typically administered one to three times daily. Some oral liquid forms may have specific instructions regarding meal timing, such as taking them thirty minutes before or after food.

Preparation and Procedural Rules

Parameter Instruction
Preparation Requirements Oral powder must be reconstituted or mixed with a liquid according to the label. IV preparations require aseptic admixture into the complete nutritional support solution.
Age-Group Rules Dosing for pediatric populations generally requires the guidance of a healthcare professional. Individuals who are pregnant or breastfeeding are advised to consult a healthcare provider prior to use.
Procedural Conditions IV administration must strictly follow established aseptic technique for infusion. Oral forms should be swallowed with water. Do not substitute one dosage form for another (e.g., tablet for powder) unless directed by a professional.

Connection to the Overall Use Protocol

These instructions define a structured approach to using L-Lysine by requiring selection of the correct labeled form and route of administration, adherence to the established maximum daily dosage, and compliance with specific preparation and procedural rules. These guidelines govern the correct intake frequency and the administration method, especially for specialized uses like intravenous nutritional support.

Recent Clinical Evidence

Research evidence / Overview of studies for Lysine

1. Evidence Landscape for Recurrent Cold Sore Outbreaks

The role of L-Lysine in conditions characterized by fluctuating or episodic manifestations (herpes simplex labialis) was evaluated, primarily using Randomized Controlled Trials (RCTs). Research examined outcomes related to physical discomfort, specifically monitoring the frequency of new outbreaks and the duration of time required for the sores to heal. These trials focused mainly on adult populations. Findings regarding consistent patterns were described as varied. Some studies reported measurements related to a change in the duration of symptoms when L-Lysine was administered. Other studies, however, described that the patterns observed for recurrence rates were not consistently different from the control group.

2. Research on Calcium Metabolism and Bone Health

Research has explored L-Lysine's influence on the body's use of calcium, a key process for maintaining structural health. This area was evaluated in short-term supplementation trials and foundational studies. The outcomes monitored were primarily biomarkers such as calcium absorption and excretion. Findings describe patterns observed in these studies where L-Lysine was associated with an increase in measured calcium absorption and a reduction in the amount of calcium lost through the urine. The certainty remains low regarding the application of these findings to long-term clinical outcomes like reduced fracture risk. The follow-up durations were limited in most human studies.

3. What Research Gaps and Uncertainty Remain

Evidence quality varies across studies, leading to uncertainty in certain areas. For the main indication of cold sores, the comparison is difficult due to variability in study design and dosage levels, meaning that data for a consistent, definitive conclusion remain insufficient. The long-term effects are not fully established for any studied indication. Furthermore, the evidence base is narrow, with limited information regarding the patterns of observation in specific populations such as children, older adults, pregnant individuals, or those with underlying chronic health conditions.

Key Studies & References

  1. Are there any supplements that show promise for cold sores but more research is needed?

Frequently Asked Questions (FAQ)

Common questions about Lysine (FAQ)

Q: What is Lysine and what is its role in the body?

A: Lysine (L-lysine) is an essential amino acid, meaning it is vital for human health but cannot be produced by the body and must be obtained through diet or supplements. It plays a crucial role in several bodily functions, including:

  • Protein synthesis: It is a building block for many proteins.
  • Enzyme production: It is necessary for making enzymes.
  • Hormone production: It is involved in creating hormones.
  • Collagen and elastin formation: It is essential for the structure of skin, tendons, and cartilage.
  • Calcium absorption: It helps the body absorb calcium, which is important for bone health.
  • Immune function: It may help support the immune system.

Q: What food sources naturally contain Lysine?

A: As an essential amino acid, Lysine is abundant in many protein-rich foods. Good sources include:

  • Meat and Poultry: Especially red meat, pork, and chicken.
  • Fish: Such as cod and sardines.
  • Dairy products: Including milk, cheese (particularly Parmesan), and yogurt.
  • Legumes: Like soybeans, lentils, and beans.
  • Eggs
  • Certain Grains: Including quinoa and amaranth.

Q: Why might someone take a Lysine supplement?

A: People often take Lysine supplements for various reasons, particularly due to its potential roles in protein building and immune function.

It is most commonly used to potentially help with cold sores (herpes simplex labialis), which are caused by the herpes simplex virus (HSV). Some evidence suggests Lysine may help prevent outbreaks or reduce their severity and healing time.

It may also be used to help ensure adequate intake in people with dietary restrictions, like those on certain vegan or vegetarian diets, as Lysine levels can be lower in some plant-based foods compared to animal sources.


Q: What is the typical daily intake of Lysine?

A: While there is no official Recommended Dietary Allowance (RDA) for Lysine specifically for all adults, the typical daily intake of Lysine from food for most adults is approximately 500 to 1,000 mg (0.5 to 1 gram).

When taken as a supplement for specific purposes, such as cold sores, the recommended dosages can vary significantly, often ranging from 500 mg to 3,000 mg daily. It is important to discuss appropriate dosing with a healthcare professional.


Q: Are there any common side effects associated with Lysine supplements?

A: Lysine supplements are generally considered safe when taken at recommended doses. Side effects are usually mild and uncommon. If they occur, they may include:

  • Mild stomach upset or abdominal pain.
  • Diarrhea.
  • Nausea.

Taking Lysine with food can sometimes help reduce stomach discomfort. If you experience severe or persistent side effects, discontinue use and consult a healthcare professional.


Q: Can Lysine interact with any medications or supplements?

A: While Lysine is generally well-tolerated, it may have potential interactions with certain substances. Notably:

  • Arginine: Lysine and the amino acid Arginine compete for absorption in the body. High doses of Lysine may potentially reduce Arginine levels and vice-versa. Arginine is sometimes used to treat or prevent blood vessel and heart conditions.
  • Calcium: Lysine may increase the absorption of Calcium in the body, which could potentially be a concern for individuals who already take high doses of Calcium supplements or certain calcium-regulating medications. Monitoring Calcium intake may be necessary.

Always inform your healthcare provider about all supplements and medications you are taking before starting Lysine.

How should Lysine be stored and disposed of?

How to Store and Dispose of Lysine

Official regulatory documents define specific requirements for storing and disposing of Lysine products to maintain stability and ensure safety.

Storage Conditions

L-Lysine preparations must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The product must be protected from excessive heat, moisture, and direct light.

To preserve integrity, the container should be kept tightly closed and remain in its original packaging. It is a mandatory requirement to keep the product out of the reach of children.

Disposal Instructions

Unused or expired Lysine must be properly discarded according to local regulations. Regulatory guidelines advise against disposing of medicine via household trash or wastewater (flushing or pouring down the sink).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Lysine found in:

A-Z Index: